These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostate cancer after exogenous testosterone treatment for impotence. Loughlin KR; Richie JP J Urol; 1997 May; 157(5):1845. PubMed ID: 9112543 [No Abstract] [Full Text] [Related]
3. Impotence therapy and cancer of the prostate. Guinan PD; Sadoughi W; Alsheik H; Ablin RJ; Alrenga D; Bush IM Am J Surg; 1976 May; 131(5):599-600. PubMed ID: 58562 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy: reassessing the risks and benefits. Shoupe D Hosp Pract (1995); 1999 Aug; 34(8):97-103, 107-8, 113-4. PubMed ID: 10459365 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer following testosterone replacement in Klinefelter syndrome. Bydder SA; Joseph DJ; Weinstein S; Stuckey BG ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832 [TBL] [Abstract][Full Text] [Related]
6. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency]. Morgunov LIu; Vertkin AL; Pushkar' DIu Urologiia; 2007; (5):49-51. PubMed ID: 18254226 [TBL] [Abstract][Full Text] [Related]
7. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer. Meza J; Weaver K; Martin S Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582 [No Abstract] [Full Text] [Related]
8. Endocrine evaluation and therapy of erectile dysfunction. McClure RD Urol Clin North Am; 1988 Feb; 15(1):53-64. PubMed ID: 3278476 [TBL] [Abstract][Full Text] [Related]
10. Androgens and male sexual function: a review of human studies. Schiavi RC; White D J Sex Marital Ther; 1976; 2(3):214-28. PubMed ID: 1034710 [TBL] [Abstract][Full Text] [Related]
11. Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male. Ahmed K; Hatzimouratidis K; Muneer A Eur Urol Focus; 2017 Oct; 3(4-5):514-516. PubMed ID: 29331623 [TBL] [Abstract][Full Text] [Related]
12. Prostatic complications of testosterone replacement therapy. Jackson JA; Waxman J; Spiekerman AM Arch Intern Med; 1989 Oct; 149(10):2365-6. PubMed ID: 2679476 [TBL] [Abstract][Full Text] [Related]
13. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid]. Mörk H; al-Taie O; Klinge O; Scheurlen M Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641 [TBL] [Abstract][Full Text] [Related]
15. [Andropause, male climacteric and crisis of the fifties: should androgens be administered?]. Martin-Du Pan R; Martin-du Pan S; Sindelar P Rev Med Suisse Romande; 1995 Mar; 115(3):257-62. PubMed ID: 7777768 [No Abstract] [Full Text] [Related]
17. [Prostate cancer associated with long-term intake of patent medicine containing methyltestosterone: a case report]. Nakata S; Hasumi M; Sato J; Ogawa A; Yamanaka H Hinyokika Kiyo; 1997 Nov; 43(11):791-3. PubMed ID: 9436023 [TBL] [Abstract][Full Text] [Related]
18. Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy. Chao C; Williams SG; Xu L; Chen J; Wallner LP; Porter KR; Jacobsen SJ Cancer Lett; 2013 Jul; 335(1):214-8. PubMed ID: 23419526 [TBL] [Abstract][Full Text] [Related]
19. Should women who have had breast cancer take hormone replacement therapy? Eden J Maturitas; 1995 Sep; 22(2):69-70. PubMed ID: 8538486 [No Abstract] [Full Text] [Related]